Statins can produce false signs of thyroid problems

2 March 2009

Cholesterol-lowering statins, used by millions of Americans to treat and prevent atherosclerosis, may falsely indicate thyroid problems,  according to researchers at Texas Health Presbyterian Hospital Dallas.  Their study, Radioiodine studies, low serum TSH, and the influence of  statin drugs, appears in the journal Thyroid.

"These findings could help physicians make quicker, more accurate  diagnoses of suspected thyroid problems," said William Harvey, a nuclear  medicine physician and author of the study. "It also has very  provocative scientific implications as we learn more about how statins  affect different systems in the body," he added.

The researchers re-examined 307 patients whose initial TSH blood tests,  the most common measure of thyroid function, showed overactive thyroids.  Symptoms of the condition, called hyperthyroidism, can include a fast  heart rate and palpitations, tremors, anxiety, weak muscles and  difficulty sleeping.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight